| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/08/2009 | US20090012091 Oximide derivatives and their therapeutical application |
| 01/08/2009 | US20090012090 Radiohalogenated Benzamide Derivatives And Their Use In Tumor Diagnosis And Tumor Therapy |
| 01/08/2009 | US20090012089 Oxazolidinone Compounds and Their Use as Metabotropic Glutamate Receptor Potentiators |
| 01/08/2009 | US20090012088 Compounds for the Treatment of Neurodegeneration and Stroke |
| 01/08/2009 | US20090012087 New Aza-Bicyclohexane Compounds Useful As Inhibitors Of Thrombin |
| 01/08/2009 | US20090012086 Use of Non-Peptidic Nk1 Receptor Antagonists for the Production of Apoptosis in Tumor Cells |
| 01/08/2009 | US20090012085 Dosage forms and methods of treatment using a tyrosine kinase inhibitor |
| 01/08/2009 | US20090012084 7-Ethoxy-4-[(2-fluoro-4-methyl-phenyl)amino]-6-(4-methylpiperazin-1-yl)cinnoline-3-carboxamide, having colony stimulating factor 1 receptor (CSF-1R) kinase inhibitory activity, used as anticarcinogenic agents |
| 01/08/2009 | US20090012083 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 01/08/2009 | US20090012082 Mediators of Hedgehog Signaling Pathways, Compositions and Uses Related Thereto |
| 01/08/2009 | US20090012081 Agents for promoting the proliferation or differentiation of stem cells or neural progenitor cells |
| 01/08/2009 | US20090012080 Sirtuin modulating compounds |
| 01/08/2009 | US20090012079 Triazolopyridine Compounds |
| 01/08/2009 | US20090012078 Fused pyrazine compounds useful for the treatment of degenerative and inflammatory diseases |
| 01/08/2009 | US20090012077 Novel Compound - 827 |
| 01/08/2009 | US20090012076 Tyrosine kinase inhibitors |
| 01/08/2009 | US20090012075 Fluorinated Arylamide Derivatives |
| 01/08/2009 | US20090012074 Arylsulfonylmethyl or arylsulfonamide substituted aromatic compounds suitable for treating disorders that respond to modulation of the Dopamine D3 receptor |
| 01/08/2009 | US20090012073 N-aroyl cyclic amines |
| 01/08/2009 | US20090012072 Fluoroquinolone compositions |
| 01/08/2009 | US20090012071 4-substituted-1h-isothiazolo[5,4-b][1,4]oxazino[2,3,4-ij]quinoline-7,8(2h,9h)-diones and related compounds as anti-infective agents |
| 01/08/2009 | US20090012070 Pesticidal heterocycles |
| 01/08/2009 | US20090012069 Novel Antidiabetic Compounds |
| 01/08/2009 | US20090012068 Condensed Imidazole Derivatives as Aldosterone Synthase Inhibitors |
| 01/08/2009 | US20090012067 Modulation of Hypothalamic Atp-Sensitive Potassium Channels |
| 01/08/2009 | US20090012066 Method of Use of Deacetylase Inhibitors |
| 01/08/2009 | US20090012065 Therapeutic applications of pro-apoptotic benzodiazepines |
| 01/08/2009 | US20090012064 Compositions controlling pH range of release and/or release rate |
| 01/08/2009 | US20090012063 Novel imidazole derivatives |
| 01/08/2009 | US20090012062 Novel Substituted Pyrazinone Derivatives for Use in Mch-1 Mediated Diseases |
| 01/08/2009 | US20090012061 A Method of Treating Cancer |
| 01/08/2009 | US20090012060 Antitumor Agent |
| 01/08/2009 | US20090012059 Dipeptidyl peptidase inhibitors |
| 01/08/2009 | US20090012058 Prophylactic or Therapeutic Agents For Allergic Ophthalmic Diseases or Allergic Nasal Diseases, Comprising Tricyclic Triazolobenzazepine Derivative |
| 01/08/2009 | US20090012057 Cardiovascular Compounds Comprising Nitric Oxide Enhancing Groups, Compositions and Methods of Use |
| 01/08/2009 | US20090012056 Quinoline Compounds Capable of Binding the Cb2 and/or the 5-Ht6 Receptor |
| 01/08/2009 | US20090012055 Piperidine derivatives such as 4-{4-[3-(2-Methoxybenzyloxy)propoxy]phenyl}-3-[3-methoxy-5-(3-methoxypropoxy)benzyloxy]piperidine, suitable as renin inhibitors, used for the treatment of hypertension, heart failure, glaucoma, cardiac infarction, kidney failure or restenosis; improved pharmacokinetics |
| 01/08/2009 | US20090012054 Cephem Compounds and Use as Antimicrobial Agents |
| 01/08/2009 | US20090012053 Use of LXR agonists for the treatment of osteoarthritis |
| 01/08/2009 | US20090012052 Method for treating er+ breast cancer |
| 01/08/2009 | US20090012051 External preparation |
| 01/08/2009 | US20090012050 Quinone Derivative 2,3-Dimethoxy-5-Methyl-6-(10-Hydroxydecyl)-1,4-Benzoquinone for the Treatment of Muscular Dystrophies |
| 01/08/2009 | US20090012049 Use of an Unsaponifiable Extract of Plant Pulp in the Treatment of Skin Ageing. |
| 01/08/2009 | US20090012048 Methods for diagnosing and treating a mycobacterium avium subspecies paratuberculosis infection |
| 01/08/2009 | US20090012047 Crystalline forms of ibandronate sodium |
| 01/08/2009 | US20090012046 Methods of Treating Mutated Hiv |
| 01/08/2009 | US20090012045 Methods of Treating Cell Proliferative Disorders |
| 01/08/2009 | US20090012044 Novel Hiv Protease Inhibitors |
| 01/08/2009 | US20090012043 Inhibitors of polysialic acid de-n-acetylase and methods for using the same |
| 01/08/2009 | US20090012042 Hydroxypropyl-Sulfobutyl-Beta-Cyclodextrin, the Preparation Method, the Analytical Method, and the Pharmacutical Application Thereof |
| 01/08/2009 | US20090012041 Use of cyclodextrin for treatment and prevention of bronchial inflammatory diseases |
| 01/08/2009 | US20090012040 Biocompatible polymers, process for their preparation and compositions containing them |
| 01/08/2009 | US20090012039 Use of methylcobalamin nasal spray to treat disorders |
| 01/08/2009 | US20090012038 Methods for microbial biofilm destruction and interference with microbial cellular physiology |
| 01/08/2009 | US20090012037 Antiviral Compounds |
| 01/08/2009 | US20090012036 Stable S-adenosyl-L-methionine |
| 01/08/2009 | US20090012035 Dendrimer conjugates of agonists and antagonists of the gpcr superfamily |
| 01/08/2009 | US20090012034 Non-Nucleoside reverse transcriptase inhibitors |
| 01/08/2009 | US20090012033 Delivery of Biologically Active Materials Using Core-Shell Tecto(Dendritic Polymers) |
| 01/08/2009 | US20090012032 novel human genes RNF43 whose expression is markedly elevated in colorectal cancers; genes and polypeptides encoded by the genes can be used in the diagnosis of a cell proliferative disease, and as target molecules for developing drugs against the disease |
| 01/08/2009 | US20090012031 EZH2 Cancer Markers |
| 01/08/2009 | US20090012030 RNAi-MEDIATED INHIBITIN OF HTRA1 FOR TREATMENT OF MACULAR DEGENERATION |
| 01/08/2009 | US20090012028 Polyglutamic acids functionalized by cationic groups and hydrophobic groups and applications thereof, in particular therapeutic applications thereof |
| 01/08/2009 | US20090012027 Biodegradable polyphosphoramidates for controlled release of bioactive substances |
| 01/08/2009 | US20090012026 Association Between the Tdoa Gene and Osteoarthritis |
| 01/08/2009 | US20090012025 Methods and Compositions for Treatment of Sepsis |
| 01/08/2009 | US20090012024 Stem Cell Markers |
| 01/08/2009 | US20090012023 Decoy-olignucleotide inhibition of cd40-expression |
| 01/08/2009 | US20090012022 Hybrid Interfering Rna |
| 01/08/2009 | US20090012021 Delivery of Sirna by Neutral Lipid Compositions |
| 01/08/2009 | US20090012020 Inhibiting formation of atherosclerotic lesions |
| 01/08/2009 | US20090012019 Methods and Compositions Related to TR4 |
| 01/08/2009 | US20090012018 Inhibition of pancretic cancer cell growth |
| 01/08/2009 | US20090012017 Polypeptide Complex that Regulates Cell Cycle and Anergy |
| 01/08/2009 | US20090012016 Short Interfering Rna and Micro-Rna Compounds and Methods of Designing, Making, and Using the Same |
| 01/08/2009 | US20090012015 Large dose ribavrin formulatons |
| 01/08/2009 | US20090012014 Compound, Composition and a Process Thereof |
| 01/08/2009 | US20090012013 Steroid modified solatrioses |
| 01/08/2009 | US20090012012 Intratracheal administration of endothelin-suppressing agents for the treatment of respiratory disorders |
| 01/08/2009 | US20090012009 Composition and Method for Treating Inflammatory Disease |
| 01/08/2009 | US20090012008 Pharmaceutical Composition for Photodynamic Therapy and a Method for Treating Oncological Diseases by Using Said Composition |
| 01/08/2009 | US20090011994 Non-basic melanin concentrating hormone receptor-1 antagonists and methods |
| 01/08/2009 | US20090011993 Novel strategies for delivery of active agents using micelles and particles |
| 01/08/2009 | US20090011990 Carbohydrate fraction and use thereof for a flat postprandial glucose response |
| 01/08/2009 | US20090011989 Treating or preventing myocardial contractile dysfunction that occurs after a myocardial infarction or other structural heart disease (e.g., end-stage valve disease) by by administering CaMK11 inhibitor, a peptide having a specific sequence of amino acids; dilated cardiomyopathy; transgenic animals |
| 01/08/2009 | US20090011986 Thiosuccinic Acid Derivatives and the Use Thereof |
| 01/08/2009 | US20090011978 Use of Surfactant Preparations for the Treatment of Surgical Adhesions |
| 01/08/2009 | US20090011975 Targeted bone marrow protection agents |
| 01/08/2009 | US20090011496 comprises supplementing the culture medium with a prostaglandin in an amount effective to promote complete hatching of the embryo (i.e., freeing of the embryo from the zona pellucida); in vitro fertilization embryo is thereby enhanced and establishment of a viable pregnancy is facilitated |
| 01/08/2009 | US20090011440 Receptor Tyrosine Kinase Signaling Pathway Analysis For Diagnosis And Therapy |
| 01/08/2009 | US20090011421 Susceptibility to bone damage |
| 01/08/2009 | US20090011060 Campsiandra angustifolia extract and methods of extracting and using such extract |
| 01/08/2009 | US20090011059 Ginger Extract For Inhibiting Human Drug Transporters |
| 01/08/2009 | US20090011055 Plasminogen Activator Inhibitor-1 Inhibitors And Methods Of Use Thereof To Modulate Lipid Metabolism |
| 01/08/2009 | US20090011051 Methods, Compositions and Articles of Manufacture for HIF Modulating Compounds |
| 01/08/2009 | US20090011045 Pharmaceutical for Hygienic Administration in the Ear |
| 01/08/2009 | US20090011041 Compositions for Correcting Age Related Changes of a Human Endocrine System and Methods for Producing a Pharmaceutical Form Bases on Said Compositions |
| 01/08/2009 | US20090011040 Use of compacted nucleic acid nanoparticles in non-viral treatments of ocular diseases |
| 01/08/2009 | US20090011035 Personal care composition |
| 01/08/2009 | US20090011034 Sustained release micropellets and process for producing the same |